中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共77条,第1-10条 帮助

条数/页: 排序方式:
NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe 期刊论文  OAI收割
EBIOMEDICINE, 2023, 卷号: 98, 页码: 18
作者:  
Wang, Bo;  Tang, Chu;  Lin, En;  Jia, Xiaohua;  Xie, Ganyuan
  |  收藏  |  浏览/下载:14/0  |  提交时间:2024/02/22
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage 期刊论文  OAI收割
CANCER MEDICINE, 2023, 页码: 14
作者:  
Chang, Shuaikang;  Xiao, Wenqin;  Xie, Yongsheng;  Xu, Zhijian;  Li, Bo
  |  收藏  |  浏览/下载:7/0  |  提交时间:2023/12/11
Synthesis, and biological evaluation of EGFR/HER2-NAMPT conjugates for tumor treatment 期刊论文  OAI收割
MOLECULAR DIVERSITY, 2023, 页码: 20
作者:  
Ding, Mengyuan;  Shen, Qianqian;  Lu, Wei;  Zhu, Shulei
  |  收藏  |  浏览/下载:62/0  |  提交时间:2023/10/17
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612
作者:  
Wang, Xiaomin;  Xu, Jun;  Sun, Yiming;  Cao, Siyuwei;  Zeng, Hanlin
  |  收藏  |  浏览/下载:24/0  |  提交时间:2023/10/17
Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 10, 页码: 7016-7037
作者:  
Li, Daqiang;  Zhang, Zhuo;  Li, Yalei;  Wang, Xinyi;  Zhong, Hanyue
  |  收藏  |  浏览/下载:18/0  |  提交时间:2023/10/17
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文  OAI收割
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  
Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun
  |  收藏  |  浏览/下载:19/0  |  提交时间:2022/11/21
Phosphoproteomics Reveals the AMPK Substrate Network in Response to DNA Damage and Histone Acetylation 期刊论文  OAI收割
GENOMICS PROTEOMICS & BIOINFORMATICS, 2022, 卷号: 20, 期号: 4, 页码: 597-613
作者:  
Jiang, Yuejing;  Cong, Xiaoji;  Jiang, Shangwen;  Dong, Ying;  Zhao, Lei
  |  收藏  |  浏览/下载:14/0  |  提交时间:2023/04/10
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKK? and overcomes gefitinib resistance in non-small cell lung cancer 期刊论文  OAI收割
CANCER BIOLOGY & MEDICINE, 2022, 卷号: 19, 期号: 8, 页码: 1172-1192
作者:  
He, Ting;  Gao, Yinglei;  Fang, Yanfen;  Zhang, Yangming;  Zhang, Shuwei
  |  收藏  |  浏览/下载:10/0  |  提交时间:2024/03/21

A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo

期刊论文  OAI收割

BIOCHEMICAL PHARMACOLOGY, 2022, 卷号: 201, 页码: 12
作者:  
Li, Yin-Ru;  Liu, Fang-Fang;  Liu, Wen-Bo;  Zhang, Yi-Fan;  Tian, Xin-Yi
  |  收藏  |  浏览/下载:24/0  |  提交时间:2022/08/16
A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo 期刊论文  OAI收割
BIOCHEMICAL PHARMACOLOGY, 2022, 卷号: 201, 页码: 115070
作者:  
Li, Yin-Ru;  Liu, Fang-Fang;  Liu, Wen-Bo;  Zhang, Yi-Fan;  Tian, Xin-Yi
  |  收藏  |  浏览/下载:10/0  |  提交时间:2024/03/21